Gabriele S.
- Country
- Germany
- Department
- 5. Medizinische Klinik Onkologie/Hämatologie
Research Overview
- Phase II Study of Total Neoadjuvant Durvalumab Plus FLOT Combination Therapy Followed by Postoperative Durvalumab in Resectable Gastroesophageal Adenocarcinoma
- Evaluation of Adjuvant Therapy with Capecitabine in Stage II Colon and Rectal Cancer Patients with ctDNA Positivity Post-Resection
- Efficacy of Post-Resection Chemotherapy with Irinotecan, Fluorouracil, and Oxaliplatin in Metastatic Colorectal Cancer: A Phase III Randomized Trial
Data & Insights
Has run more than one trial at 143 of 369 partner sites.
Specializations
Gastrointestinal Oncology
Specializes in treating esophagogastric adenocarcinomas and exploring innovative therapeutic approaches for gastric cancer, with particular focus on HER2-positive cases and advanced disease states.
- Gastroesophageal Junction Cancers
- Advanced Gastric Adenocarcinomas
- HER2-Positive Gastric Cancers
Investigates perioperative treatment strategies and targeted therapies for gastric malignancies.
Colorectal Cancer Research
Focuses on developing treatment strategies for metastatic colorectal cancer and investigating novel approaches for resectable colon cancer.
- Advanced Colon Cancer
- Stage II Colon Cancer
- Post-resection Therapy
Studies preoperative and postoperative treatment options in various stages of colorectal disease.
Hematologic Oncology
Conducts research in advanced Hodgkin Lymphoma treatment, evaluating novel therapeutic combinations and treatment optimization strategies.
- Advanced Stage Lymphoma
- Treatment-Related Morbidity
- Progressive Disease Management
Explores innovative treatment protocols aimed at reducing toxicity while maintaining efficacy.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.